ERAS Erasca, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Erasca (ERAS) Stock: Buy, Sell, or Hold?

$16.80
+1.32 (+8.53%) ▲
5d: +12.68% 30d: +13.67% 90d: -5.94%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (26%)
Quality Score
39/100
Position
EXTENDED
30-Day Fair Range
$13.97 – $15.54
Position: EXTENDED
Forward P/E & Valuation
-24.8x
Next 12M consensus est.
Wall Street Target
$24.11
+55.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$13.11 / $17.34
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ERAS shows conflicting indicators. Wait for confirmation before entering.
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Nov 6, 2026 at $15.36 · last confirmed Nov 10, 2026

Strength: 6.2/10

Get Alerted When ERAS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ERAS is currently trading at $16.80, which is considered extended relative to its 30-day fair value range of $13.97 to $15.54.

Technical Outlook: Technically, ERAS is in a strong downtrend. Immediate support is located at $13.11, while resistance sits at $17.34. The stock is showing strong short-term momentum, up 8.5% recently.

Market Sentiment: ERAS scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $24.11 (+55.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $13.97 - $15.54
Company Quality Score 39/100 (SELL)
Volume Confirmation HIGH
Confidence Score 26.3%

Trading Range & Key Levels

30-Day Trading Range $13.97 - $15.54
Current vs Trading Range EXTENDED
Support Level $13.11
Resistance Level $17.34
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Protect Your Profits

Holding ERAS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price extended above range (+8.1% above its trading range)
  • BEARISH: Weak technical setup (23/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+8.5%)
  • BULLISH: Trading 55.8% below Wall St target ($24.11)
  • WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -24.84
Wall Street Target $24.11 (+55.8%)
Share ERAS Analysis

Share this live ERAS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ERAS)

Bullish 3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages by bullish traders compare $ERAS with $VSTM and $RVMD, discussing the importance of considering both the numerator and denominator in financial figures.
Key Retail Themes: Stock comparison Financial analysis
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 3:33 PM ET
Data refreshes hourly during market hours. Next update: 4:33 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ERAS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$107 61 BUY
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 37 SELL
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$689 56 HOLD
RZLT
Rezolute Inc
STRONG BUY
11 analysts
$10 72 BUY
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$86 46 HOLD

Advanced ERAS Option Strategies

Professional options setups generated by AI based on today's ERAS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ERAS Research Pages
ERAS Technical Chart ERAS Price Prediction ERAS Intrinsic Value DCF ERAS Earnings Date Why is ERAS Moving Today? ERAS Investment Advisor ERAS Fair Price Analyzer ERAS Options Chain ERAS Options Advisor ERAS Options Analysis ERAS Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals